These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23219029)

  • 1. Clobazam therapy of refractory epilepsy in tuberous sclerosis complex.
    Jennesson M; van Eeghen AM; Caruso PA; Paolini JL; Thiele EA
    Epilepsy Res; 2013 May; 104(3):269-74. PubMed ID: 23219029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of clobazam as add-on therapy for refractory epilepsy: experience at a US epilepsy center.
    Montenegro MA; Arif H; Nahm EA; Resor SR; Hirsch LJ
    Clin Neuropharmacol; 2008; 31(6):333-8. PubMed ID: 19050410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clobazam in treatment of refractory epilepsy: the Canadian experience. A retrospective study. Canadian Clobazam Cooperative Group.
    Epilepsia; 1991; 32(3):407-16. PubMed ID: 2044502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everolimus treatment of refractory epilepsy in tuberous sclerosis complex.
    Krueger DA; Wilfong AA; Holland-Bouley K; Anderson AE; Agricola K; Tudor C; Mays M; Lopez CM; Kim MO; Franz DN
    Ann Neurol; 2013 Nov; 74(5):679-87. PubMed ID: 23798472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term use of clobazam in Lennox-Gastaut syndrome: experience in a single tertiary epilepsy center.
    Lee EH; Yum MS; Choi HW; Ko TS
    Clin Neuropharmacol; 2013; 36(1):4-7. PubMed ID: 23334068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epileptic spasms in tuberous sclerosis complex.
    Hsieh DT; Jennesson MM; Thiele EA
    Epilepsy Res; 2013 Sep; 106(1-2):200-10. PubMed ID: 23796861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epilepsy in TSC: certain etiology does not mean certain prognosis.
    Vignoli A; La Briola F; Turner K; Scornavacca G; Chiesa V; Zambrelli E; Piazzini A; Savini MN; Alfano RM; Canevini MP
    Epilepsia; 2013 Dec; 54(12):2134-42. PubMed ID: 24304436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Everolimus in tuberous sclerosis patients with intractable epilepsy: a treatment option?
    Wiegand G; May TW; Ostertag P; Boor R; Stephani U; Franz DN
    Eur J Paediatr Neurol; 2013 Nov; 17(6):631-8. PubMed ID: 23845174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lacosamide use in the treatment of refractory epilepsy in tuberous sclerosis complex.
    Geffrey AL; Belt OD; Paolini JL; Thiele EA
    Epilepsy Res; 2015 May; 112():72-5. PubMed ID: 25847341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of low-dose, add-on therapy of clobazam (CLB) is produced by its major metabolite, N-desmethyl-CLB.
    Kinoshita M; Ikeda A; Begum T; Terada K; Shibasaki H
    J Neurol Sci; 2007 Dec; 263(1-2):44-8. PubMed ID: 17588610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retention rate of clobazam, topiramate and lamotrigine in children with intractable epilepsies at 1 year.
    Mills JK; Lewis TG; Mughal K; Ali I; Ugur A; Whitehouse WP
    Seizure; 2011 Jun; 20(5):402-5. PubMed ID: 21414810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seizure remission and antiepileptic drug discontinuation in children with tuberous sclerosis complex.
    Sparagana SP; Delgado MR; Batchelor LL; Roach ES
    Arch Neurol; 2003 Sep; 60(9):1286-9. PubMed ID: 12975296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clobazam in the treatment of Lennox-Gastaut syndrome.
    Conry JA; Ng YT; Paolicchi JM; Kernitsky L; Mitchell WG; Ritter FJ; Collins SD; Tracy K; Kormany WN; Abdulnabi R; Riley B; Stolle J
    Epilepsia; 2009 May; 50(5):1158-66. PubMed ID: 19170737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term effect of everolimus on epilepsy and growth in children under 3 years of age treated for subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
    Kotulska K; Chmielewski D; Borkowska J; Jurkiewicz E; Kuczyński D; Kmieć T; Łojszczyk B; Dunin-Wąsowicz D; Jóźwiak S
    Eur J Paediatr Neurol; 2013 Sep; 17(5):479-85. PubMed ID: 23567018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clobazam: effect on frequency of seizures and safety profile in different subgroups of children with epilepsy.
    Klehm J; Thome-Souza S; Sánchez Fernández I; Bergin AM; Bolton J; Harini C; Kadish NE; Libenson M; Peters J; Poduri A; Rotenberg A; Takeoka M; Bourgeois B; Loddenkemper T
    Pediatr Neurol; 2014 Jul; 51(1):60-6. PubMed ID: 24830765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cannabidiol as a new treatment for drug-resistant epilepsy in tuberous sclerosis complex.
    Hess EJ; Moody KA; Geffrey AL; Pollack SF; Skirvin LA; Bruno PL; Paolini JL; Thiele EA
    Epilepsia; 2016 Oct; 57(10):1617-1624. PubMed ID: 27696387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Refractory epilepsy in tuberous sclerosis: vagus nerve stimulation with or without subsequent resective surgery.
    Elliott RE; Carlson C; Kalhorn SP; Moshel YA; Weiner HL; Devinsky O; Doyle WK
    Epilepsy Behav; 2009 Nov; 16(3):454-60. PubMed ID: 19767244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian target of rapamycin inhibitors for intractable epilepsy and subependymal giant cell astrocytomas in tuberous sclerosis complex.
    Cardamone M; Flanagan D; Mowat D; Kennedy SE; Chopra M; Lawson JA
    J Pediatr; 2014 May; 164(5):1195-200. PubMed ID: 24518170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberous sclerosis complex and the ketogenic diet.
    Kossoff EH; Thiele EA; Pfeifer HH; McGrogan JR; Freeman JM
    Epilepsia; 2005 Oct; 46(10):1684-6. PubMed ID: 16190943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyst-like tubers are associated with TSC2 and epilepsy in tuberous sclerosis complex.
    Chu-Shore CJ; Major P; Montenegro M; Thiele E
    Neurology; 2009 Mar; 72(13):1165-9. PubMed ID: 19332694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.